Zhou et al. (98) identified that rhamnocitrin may decrease serum testosterone levels in letrozole-induced PCOS model SD rats by reducing malondialdehyde (MDA) production and increasing serum superoxide dismutase (SOD) activity, resulting in fewer cysts and improved ovarian morphology. This evidence concerns the gene SOD1 and polycystic ovary syndrome.